In clinical trials, neuroAD technology has shown measurable cognitive improvement after just a few weeks. The results, published in peer-reviewed journal, showed marked reversal of disease progression with patients improving to a state comparable to two years before treatment initiation. Trials also indicated that improvement is maintained for at least six months post treatment.
For more information about participating in a clinical trial, please contact Neuronix at email@example.com
NeuroAD is an investigational device, currently not available in the USA